問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
何恭之
下載
2025-02-03 - 2033-05-03
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2025-08-01 - 2032-12-31
Participate Sites2Sites
Recruiting2Sites
2025-04-04 - 2029-12-07
Participate Sites3Sites
Recruiting3Sites
2024-01-26 - 2029-02-28
Participate Sites5Sites
Recruiting5Sites
2022-08-01 - 2025-07-31
Participate Sites1Sites
Recruiting1Sites
2023-08-01 - 2026-07-31
2022-01-01 - 2025-12-31
2021-06-30 - 2023-12-31
Hepatic Carcinoma
Dolacga (Lyophilized product for the preparation of gallium Ga68-Dolacga injection)
2021-11-01 - 2022-08-29
Participate Sites6Sites
Recruiting6Sites
全部
